Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf1
|
ENSMUSG00000054191.7 | Kruppel-like factor 1 (erythroid) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_84902077_84902228 | Klf1 | 224 | 0.806757 | 0.55 | 1.6e-05 | Click! |
chr8_84901775_84902039 | Klf1 | 21 | 0.929009 | 0.54 | 2.3e-05 | Click! |
chr8_84901231_84901392 | Klf1 | 617 | 0.446899 | 0.52 | 4.0e-05 | Click! |
chr8_84900828_84901106 | Klf1 | 961 | 0.276773 | 0.50 | 9.2e-05 | Click! |
chr8_84903360_84903717 | Klf1 | 1610 | 0.152564 | 0.46 | 4.8e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14354416_14355184 | 40.16 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr2_153492229_153493481 | 34.96 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr5_137530580_137532081 | 32.89 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr11_117838543_117838973 | 30.07 |
Afmid |
arylformamidase |
6485 |
0.09 |
chr8_70698268_70700333 | 27.86 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr7_127768560_127769629 | 26.48 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chrX_142680720_142682167 | 24.63 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr14_69321815_69322332 | 23.97 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 23.97 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr8_120486990_120488549 | 23.89 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr11_100938783_100940230 | 23.89 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr2_174329445_174331091 | 21.94 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr19_56391765_56391943 | 21.83 |
Nrap |
nebulin-related anchoring protein |
1817 |
0.31 |
chr13_58006958_58007325 | 21.71 |
Mir874 |
microRNA 874 |
16059 |
0.21 |
chr10_127508848_127510720 | 21.35 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr2_170130477_170131578 | 20.94 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr17_34898151_34899707 | 20.82 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr1_46852832_46854284 | 20.71 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
488 |
0.78 |
chrX_51204673_51205680 | 20.11 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr2_24385099_24385869 | 20.04 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
131 |
0.95 |
chr17_70850487_70852089 | 19.84 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr7_110914639_110914941 | 19.46 |
Mrvi1 |
MRV integration site 1 |
8913 |
0.17 |
chr2_153577050_153577347 | 19.42 |
Nol4l |
nucleolar protein 4-like |
47227 |
0.11 |
chr14_20793233_20794132 | 19.27 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr14_48475621_48476075 | 19.14 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr7_17059591_17061170 | 18.64 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
1846 |
0.19 |
chr10_69908447_69908713 | 18.36 |
Ank3 |
ankyrin 3, epithelial |
6285 |
0.32 |
chr15_98608664_98610204 | 18.22 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr4_141750503_141750994 | 17.75 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4076 |
0.15 |
chr1_167384256_167384453 | 17.66 |
Mgst3 |
microsomal glutathione S-transferase 3 |
9487 |
0.15 |
chr7_17058026_17058724 | 17.62 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
159 |
0.9 |
chr10_80576603_80578409 | 17.56 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr5_140647773_140649317 | 17.11 |
Ttyh3 |
tweety family member 3 |
452 |
0.77 |
chr5_140034121_140034770 | 17.11 |
Gm43702 |
predicted gene 43702 |
2269 |
0.28 |
chr14_115040506_115042372 | 17.07 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr6_99520900_99522395 | 17.00 |
Foxp1 |
forkhead box P1 |
485 |
0.83 |
chr6_124919273_124920636 | 16.87 |
Ptms |
parathymosin |
149 |
0.88 |
chr19_4282702_4283651 | 16.85 |
Ankrd13d |
ankyrin repeat domain 13 family, member D |
39 |
0.93 |
chrX_7967908_7968074 | 16.52 |
Gata1 |
GATA binding protein 1 |
81 |
0.93 |
chr1_130731762_130732102 | 16.44 |
AA986860 |
expressed sequence AA986860 |
44 |
0.94 |
chr11_3289074_3290615 | 16.43 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr15_81585272_81586453 | 16.42 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr3_30507827_30509444 | 16.33 |
Mecom |
MDS1 and EVI1 complex locus |
852 |
0.52 |
chr14_55824498_55825973 | 16.33 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
198 |
0.87 |
chr11_94468409_94469097 | 16.14 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4888 |
0.15 |
chr8_122323502_122324203 | 16.12 |
Zfpm1 |
zinc finger protein, multitype 1 |
9846 |
0.13 |
chr17_56958124_56958403 | 16.03 |
Gm49887 |
predicted gene, 49887 |
57 |
0.94 |
chr9_109094576_109096217 | 16.02 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr19_43493324_43493679 | 15.94 |
Cnnm1 |
cyclin M1 |
15 |
0.97 |
chr11_74572712_74572939 | 15.91 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
17299 |
0.18 |
chr11_60104775_60106860 | 15.81 |
Rai1 |
retinoic acid induced 1 |
640 |
0.67 |
chr1_134742054_134742220 | 15.73 |
Syt2 |
synaptotagmin II |
6440 |
0.17 |
chr10_77211136_77211324 | 15.72 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44682 |
0.11 |
chr12_76673740_76674235 | 15.64 |
Sptb |
spectrin beta, erythrocytic |
36036 |
0.15 |
chr17_48300203_48300827 | 15.41 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
129 |
0.94 |
chr11_69366461_69367262 | 15.34 |
Chd3 |
chromodomain helicase DNA binding protein 3 |
2082 |
0.14 |
chr2_119299892_119301103 | 15.33 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
11710 |
0.1 |
chr5_137349031_137350198 | 15.30 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr13_21831513_21832288 | 15.27 |
Hist1h4n |
histone cluster 1, H4n |
296 |
0.63 |
chr4_140701770_140702866 | 15.19 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr6_125095392_125097556 | 15.15 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr10_69910043_69910940 | 15.15 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr11_11684707_11686418 | 14.97 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr1_86525613_86527056 | 14.82 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr11_94630351_94630909 | 14.81 |
Lrrc59 |
leucine rich repeat containing 59 |
816 |
0.45 |
chr4_133057809_133058081 | 14.80 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
8304 |
0.2 |
chr2_118662761_118664171 | 14.80 |
Pak6 |
p21 (RAC1) activated kinase 6 |
163 |
0.94 |
chr2_153528510_153529333 | 14.79 |
Nol4l |
nucleolar protein 4-like |
1050 |
0.54 |
chr3_51340298_51341882 | 14.74 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr11_98741567_98742727 | 14.71 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr1_134559997_134561478 | 14.65 |
Kdm5b |
lysine (K)-specific demethylase 5B |
530 |
0.69 |
chr17_5891885_5892291 | 14.53 |
Gm8376 |
predicted gene 8376 |
46999 |
0.1 |
chr16_11423409_11423900 | 14.51 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr15_58140746_58142050 | 14.46 |
Wdyhv1 |
WDYHV motif containing 1 |
6 |
0.96 |
chr4_33923766_33925291 | 14.44 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr1_166002288_166003185 | 14.43 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr9_48340771_48341057 | 14.37 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
16 |
0.98 |
chr11_106674335_106675138 | 14.34 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
11410 |
0.17 |
chr7_19824688_19824985 | 14.21 |
Bcl3 |
B cell leukemia/lymphoma 3 |
2066 |
0.13 |
chr1_160053555_160053710 | 14.17 |
4930523C07Rik |
RIKEN cDNA 4930523C07 gene |
9185 |
0.16 |
chr5_140439026_140439687 | 14.16 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr16_94370280_94371726 | 14.15 |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
12 |
0.69 |
chr4_118568737_118569073 | 14.07 |
Tmem125 |
transmembrane protein 125 |
24861 |
0.1 |
chr19_55258073_55258273 | 14.02 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
4804 |
0.19 |
chr12_80109325_80110752 | 14.01 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
2956 |
0.17 |
chr10_42626054_42626225 | 13.96 |
Ostm1 |
osteopetrosis associated transmembrane protein 1 |
42301 |
0.13 |
chr17_28345881_28346331 | 13.95 |
Tead3 |
TEA domain family member 3 |
4240 |
0.11 |
chr11_69996486_69997590 | 13.84 |
Phf23 |
PHD finger protein 23 |
47 |
0.91 |
chr15_76253653_76253816 | 13.82 |
Mir6953 |
microRNA 6953 |
5543 |
0.07 |
chr11_116077472_116077863 | 13.77 |
Unc13d |
unc-13 homolog D |
43 |
0.95 |
chr5_109557850_109558797 | 13.66 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr7_16313509_16314466 | 13.61 |
Bbc3 |
BCL2 binding component 3 |
470 |
0.71 |
chr11_74831594_74833056 | 13.60 |
Mnt |
max binding protein |
1405 |
0.31 |
chr3_127930366_127930648 | 13.58 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14335 |
0.14 |
chr1_134424042_134424208 | 13.50 |
Adipor1 |
adiponectin receptor 1 |
8561 |
0.11 |
chr8_122546140_122546405 | 13.50 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
5057 |
0.1 |
chr10_128525093_128526268 | 13.50 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr15_102235360_102236054 | 13.47 |
Itgb7 |
integrin beta 7 |
3763 |
0.11 |
chr10_12868058_12869331 | 13.42 |
Utrn |
utrophin |
413 |
0.85 |
chr15_86105433_86105656 | 13.34 |
Gm15722 |
predicted gene 15722 |
15484 |
0.17 |
chr1_135250803_135250980 | 13.23 |
Gm26642 |
predicted gene, 26642 |
2330 |
0.18 |
chr7_35118789_35119702 | 13.20 |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
48 |
0.82 |
chr11_96956109_96956306 | 13.17 |
D030028A08Rik |
RIKEN cDNA D030028A08 gene |
11895 |
0.08 |
chr2_48949106_48950119 | 13.16 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr10_81095272_81095757 | 13.14 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2939 |
0.1 |
chr5_149678355_149679261 | 13.11 |
B3glct |
beta-3-glucosyltransferase |
578 |
0.71 |
chr5_113789227_113789902 | 13.07 |
Tmem119 |
transmembrane protein 119 |
10882 |
0.09 |
chr11_98750501_98751849 | 13.07 |
Thra |
thyroid hormone receptor alpha |
2411 |
0.15 |
chr2_119304636_119305204 | 13.04 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
16133 |
0.1 |
chr9_57644752_57646108 | 12.89 |
Csk |
c-src tyrosine kinase |
187 |
0.91 |
chr17_84154262_84154638 | 12.87 |
Gm19696 |
predicted gene, 19696 |
1976 |
0.29 |
chr5_100572149_100572573 | 12.86 |
Plac8 |
placenta-specific 8 |
116 |
0.95 |
chr11_103346676_103347015 | 12.85 |
Arhgap27os3 |
Rho GTPase activating protein 27, opposite strand 3 |
2092 |
0.19 |
chr9_103007679_103008651 | 12.76 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
11 |
0.97 |
chr5_129742979_129743345 | 12.71 |
Nipsnap2 |
nipsnap homolog 2 |
9496 |
0.1 |
chr10_79682967_79683630 | 12.60 |
Cdc34 |
cell division cycle 34 |
772 |
0.38 |
chr4_106804255_106804459 | 12.53 |
Acot11 |
acyl-CoA thioesterase 11 |
641 |
0.69 |
chr1_133797348_133797649 | 12.52 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
3538 |
0.18 |
chr10_81349169_81349745 | 12.49 |
Hmg20b |
high mobility group 20B |
372 |
0.62 |
chr3_144198270_144199266 | 12.43 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr11_12036502_12038049 | 12.38 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr5_64811569_64811963 | 12.33 |
Klf3 |
Kruppel-like factor 3 (basic) |
573 |
0.7 |
chr2_127371183_127371562 | 12.31 |
Adra2b |
adrenergic receptor, alpha 2b |
8086 |
0.14 |
chr11_113651275_113651628 | 12.25 |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
1372 |
0.29 |
chr11_117968531_117970182 | 12.24 |
Socs3 |
suppressor of cytokine signaling 3 |
95 |
0.96 |
chr5_115436438_115437458 | 12.14 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr18_39381150_39381709 | 12.09 |
Gm15337 |
predicted gene 15337 |
7996 |
0.2 |
chr7_25209148_25209349 | 12.08 |
Mir7048 |
microRNA 7048 |
8477 |
0.08 |
chrX_123721926_123722462 | 12.07 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr2_25982690_25983958 | 12.02 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr8_94733906_94734089 | 12.01 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
11593 |
0.12 |
chrX_94540282_94541447 | 12.00 |
Maged1 |
melanoma antigen, family D, 1 |
1126 |
0.39 |
chr7_16815354_16816404 | 12.00 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr9_120114727_120115009 | 11.96 |
Slc25a38 |
solute carrier family 25, member 38 |
18 |
0.94 |
chr17_28809053_28809624 | 11.96 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
321 |
0.81 |
chr1_130462634_130463277 | 11.92 |
Cd55 |
CD55 molecule, decay accelerating factor for complement |
211 |
0.66 |
chr2_60209324_60210635 | 11.88 |
Marchf7 |
membrane associated ring-CH-type finger 7 |
66 |
0.6 |
chr8_69995796_69997172 | 11.86 |
Gatad2a |
GATA zinc finger domain containing 2A |
100 |
0.95 |
chrX_123943434_123943951 | 11.86 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr10_76642712_76643426 | 11.84 |
Col6a2 |
collagen, type VI, alpha 2 |
19439 |
0.14 |
chr5_146679205_146679645 | 11.83 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
27197 |
0.15 |
chr4_133057380_133057808 | 11.77 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
8655 |
0.19 |
chr11_60176319_60177391 | 11.76 |
Rai1 |
retinoic acid induced 1 |
976 |
0.44 |
chr1_180903101_180903294 | 11.73 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1096 |
0.32 |
chrX_123500550_123501093 | 11.71 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr8_84838620_84839103 | 11.61 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
181 |
0.86 |
chr15_99029765_99030391 | 11.57 |
Tuba1c |
tubulin, alpha 1C |
187 |
0.88 |
chr8_105304651_105305257 | 11.57 |
Elmo3 |
engulfment and cell motility 3 |
647 |
0.33 |
chr5_115049804_115049955 | 11.54 |
Gm13827 |
predicted gene 13827 |
3961 |
0.12 |
chr4_148902862_148903422 | 11.53 |
Casz1 |
castor zinc finger 1 |
1993 |
0.3 |
chrX_123271195_123271712 | 11.53 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chr18_80986631_80988064 | 11.51 |
Gm27239 |
predicted gene 27239 |
109 |
0.87 |
chr18_75974467_75974618 | 11.49 |
1700003O11Rik |
RIKEN cDNA 1700003O11 gene |
41135 |
0.18 |
chr11_95990909_95991822 | 11.49 |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
8754 |
0.09 |
chr19_60799907_60800171 | 11.46 |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
9381 |
0.11 |
chr11_95808504_95808830 | 11.43 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr13_59795759_59796072 | 11.42 |
Tut7 |
terminal uridylyl transferase 7 |
1215 |
0.28 |
chr3_65658208_65659857 | 11.42 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr2_72196283_72196475 | 11.42 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
2420 |
0.29 |
chr3_88532663_88533971 | 11.40 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chr17_25942773_25943121 | 11.39 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
85 |
0.91 |
chr7_25686729_25687529 | 11.38 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr11_78982143_78982376 | 11.35 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2572 |
0.27 |
chr1_39900211_39901700 | 11.34 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
42 |
0.98 |
chr12_83579151_83579469 | 11.29 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
16377 |
0.14 |
chr2_91256510_91257912 | 11.29 |
Pacsin3 |
protein kinase C and casein kinase substrate in neurons 3 |
118 |
0.94 |
chr19_7416766_7418168 | 11.28 |
2700081O15Rik |
RIKEN cDNA 2700081O15 gene |
158 |
0.91 |
chrX_101299536_101300464 | 11.27 |
Nlgn3 |
neuroligin 3 |
474 |
0.66 |
chr17_28823421_28823710 | 11.27 |
Brpf3 |
bromodomain and PHD finger containing, 3 |
7 |
0.93 |
chr15_102017591_102018334 | 11.27 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr15_95917407_95917565 | 11.24 |
Ano6 |
anoctamin 6 |
21108 |
0.17 |
chr11_70021148_70021981 | 11.23 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
2356 |
0.11 |
chr17_12182593_12182980 | 11.23 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
7135 |
0.2 |
chr5_118483541_118483890 | 11.20 |
Gm15754 |
predicted gene 15754 |
3252 |
0.26 |
chr4_46407004_46407329 | 11.17 |
Hemgn |
hemogen |
2930 |
0.18 |
chr19_53329198_53330470 | 11.17 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr11_116077910_116078580 | 11.16 |
Unc13d |
unc-13 homolog D |
284 |
0.82 |
chr1_133800867_133801593 | 11.10 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
189 |
0.93 |
chr1_118389237_118390220 | 11.04 |
Clasp1 |
CLIP associating protein 1 |
211 |
0.93 |
chr11_117790740_117791162 | 11.02 |
Tmc8 |
transmembrane channel-like gene family 8 |
237 |
0.58 |
chr16_58661948_58662241 | 10.95 |
Gm49701 |
predicted gene, 49701 |
6850 |
0.13 |
chr13_65122167_65122342 | 10.95 |
Gm3785 |
predicted gene 3785 |
3624 |
0.13 |
chr1_75445167_75446076 | 10.91 |
Gmppa |
GDP-mannose pyrophosphorylase A |
3397 |
0.11 |
chr15_83424091_83424275 | 10.87 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
393 |
0.83 |
chr4_152092896_152093080 | 10.85 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
3731 |
0.15 |
chr1_151198225_151198491 | 10.85 |
Gm47995 |
predicted gene, 47995 |
90 |
0.94 |
chr8_90907824_90909226 | 10.80 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
89 |
0.52 |
chr11_115903493_115903793 | 10.79 |
Smim5 |
small integral membrane protein 5 |
3441 |
0.11 |
chrX_168673064_168674616 | 10.77 |
Msl3 |
MSL complex subunit 3 |
58 |
0.98 |
chr4_150518987_150519148 | 10.75 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
30674 |
0.18 |
chr12_71832274_71832639 | 10.75 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
1293 |
0.47 |
chr19_6969291_6970359 | 10.73 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chrX_11664322_11665096 | 10.69 |
Gm14513 |
predicted gene 14513 |
19415 |
0.24 |
chr5_148935398_148935729 | 10.68 |
Katnal1 |
katanin p60 subunit A-like 1 |
6243 |
0.1 |
chr12_8770800_8772245 | 10.68 |
Sdc1 |
syndecan 1 |
109 |
0.78 |
chr8_94183221_94183742 | 10.67 |
Gm39228 |
predicted gene, 39228 |
192 |
0.89 |
chr15_5143382_5144653 | 10.67 |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
126 |
0.93 |
chr7_45059162_45059688 | 10.66 |
Prrg2 |
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
2227 |
0.09 |
chr14_63110426_63110600 | 10.62 |
Gm23629 |
predicted gene, 23629 |
10977 |
0.12 |
chr7_99803718_99803873 | 10.62 |
F730035P03Rik |
RIKEN cDNA F730035P03 gene |
22256 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.2 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
11.3 | 33.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
11.0 | 32.9 | GO:0002432 | granuloma formation(GO:0002432) |
9.9 | 29.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
9.7 | 29.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
9.0 | 27.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
8.5 | 34.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
8.4 | 25.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
8.1 | 8.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
7.9 | 23.8 | GO:0036166 | phenotypic switching(GO:0036166) |
7.8 | 31.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
7.6 | 22.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
7.4 | 22.3 | GO:0008050 | female courtship behavior(GO:0008050) |
6.9 | 20.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
6.8 | 27.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
6.7 | 20.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
6.7 | 26.8 | GO:0070836 | caveola assembly(GO:0070836) |
6.6 | 33.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
6.6 | 19.7 | GO:1902896 | terminal web assembly(GO:1902896) |
6.5 | 13.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.4 | 12.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
6.3 | 12.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
6.3 | 12.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
6.1 | 49.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
6.0 | 17.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
5.9 | 17.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
5.9 | 23.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
5.8 | 29.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
5.8 | 17.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
5.8 | 23.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
5.8 | 11.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
5.8 | 17.3 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
5.8 | 23.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
5.7 | 5.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
5.6 | 5.6 | GO:0002159 | desmosome assembly(GO:0002159) |
5.5 | 5.5 | GO:0031498 | chromatin disassembly(GO:0031498) |
5.5 | 16.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
5.5 | 11.0 | GO:0050904 | diapedesis(GO:0050904) |
5.5 | 21.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
5.4 | 21.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
5.2 | 15.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
5.2 | 15.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
5.1 | 15.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
5.0 | 19.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.9 | 14.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
4.9 | 19.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
4.8 | 4.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
4.8 | 14.3 | GO:0000087 | mitotic M phase(GO:0000087) |
4.8 | 71.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
4.7 | 14.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
4.6 | 22.9 | GO:0070627 | ferrous iron import(GO:0070627) |
4.5 | 27.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
4.5 | 13.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
4.4 | 17.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
4.4 | 22.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.4 | 4.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
4.4 | 4.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
4.4 | 13.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.4 | 4.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
4.3 | 13.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.3 | 13.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
4.3 | 12.9 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
4.3 | 30.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
4.3 | 4.3 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
4.3 | 25.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
4.2 | 21.2 | GO:1904970 | brush border assembly(GO:1904970) |
4.2 | 12.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
4.2 | 12.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
4.2 | 21.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
4.2 | 8.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.2 | 16.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
4.1 | 4.1 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
4.1 | 12.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
4.1 | 4.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
4.0 | 12.1 | GO:0007525 | somatic muscle development(GO:0007525) |
4.0 | 40.2 | GO:0000050 | urea cycle(GO:0000050) |
4.0 | 11.9 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
4.0 | 19.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
4.0 | 11.9 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
3.9 | 23.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
3.9 | 23.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
3.9 | 3.9 | GO:2000591 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
3.9 | 7.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
3.9 | 15.5 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.9 | 11.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
3.8 | 3.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.8 | 15.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.8 | 3.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
3.8 | 18.9 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
3.8 | 15.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
3.8 | 11.3 | GO:0040031 | snRNA modification(GO:0040031) |
3.8 | 15.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.8 | 7.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
3.7 | 7.5 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
3.7 | 14.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.7 | 51.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
3.7 | 18.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
3.7 | 14.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.7 | 11.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
3.7 | 3.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
3.6 | 10.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 18.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.6 | 7.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
3.6 | 14.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
3.6 | 10.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.6 | 7.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
3.6 | 14.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
3.6 | 28.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
3.6 | 7.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
3.6 | 7.1 | GO:0045472 | response to ether(GO:0045472) |
3.5 | 28.3 | GO:0032782 | bile acid secretion(GO:0032782) |
3.5 | 7.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
3.5 | 14.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
3.5 | 17.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
3.5 | 7.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
3.5 | 14.0 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
3.5 | 10.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.5 | 7.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
3.5 | 17.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.5 | 10.4 | GO:0018343 | protein farnesylation(GO:0018343) |
3.5 | 31.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
3.5 | 13.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.4 | 17.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.4 | 3.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
3.4 | 3.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
3.4 | 20.5 | GO:1901563 | response to camptothecin(GO:1901563) |
3.4 | 13.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
3.4 | 10.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.4 | 10.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
3.4 | 13.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
3.4 | 10.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
3.4 | 10.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
3.4 | 3.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
3.4 | 10.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.3 | 23.4 | GO:0001842 | neural fold formation(GO:0001842) |
3.3 | 23.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
3.3 | 3.3 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
3.3 | 3.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.3 | 16.5 | GO:0072553 | terminal button organization(GO:0072553) |
3.3 | 9.9 | GO:0032439 | endosome localization(GO:0032439) |
3.3 | 9.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.3 | 13.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
3.3 | 13.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
3.2 | 22.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.2 | 9.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
3.2 | 12.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
3.2 | 19.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.2 | 6.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.2 | 9.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
3.2 | 12.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.2 | 12.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
3.2 | 19.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
3.2 | 34.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
3.2 | 28.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.1 | 22.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.1 | 6.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.1 | 3.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
3.1 | 9.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.1 | 9.4 | GO:0043622 | cortical microtubule organization(GO:0043622) |
3.1 | 24.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
3.1 | 12.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.1 | 15.4 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
3.1 | 6.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
3.1 | 6.1 | GO:0015793 | glycerol transport(GO:0015793) |
3.1 | 3.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
3.1 | 9.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.1 | 27.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
3.1 | 9.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.1 | 9.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
3.0 | 12.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
3.0 | 24.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
3.0 | 24.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
3.0 | 3.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
3.0 | 21.0 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
3.0 | 3.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
3.0 | 12.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
3.0 | 11.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
3.0 | 11.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
3.0 | 5.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
3.0 | 14.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
3.0 | 8.9 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
3.0 | 11.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
2.9 | 11.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.9 | 2.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
2.9 | 5.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.9 | 2.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.9 | 17.5 | GO:0044351 | macropinocytosis(GO:0044351) |
2.9 | 8.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.9 | 8.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.9 | 11.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
2.9 | 2.9 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
2.9 | 8.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.9 | 8.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.9 | 8.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
2.9 | 22.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.9 | 5.7 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.9 | 8.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.8 | 5.7 | GO:0061010 | gall bladder development(GO:0061010) |
2.8 | 8.5 | GO:0008228 | opsonization(GO:0008228) |
2.8 | 25.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.8 | 14.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.8 | 5.6 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.8 | 8.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.8 | 5.6 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
2.8 | 11.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.8 | 13.9 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.8 | 5.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.8 | 2.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.8 | 11.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.8 | 63.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.7 | 21.9 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
2.7 | 19.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.7 | 13.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.7 | 2.7 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.7 | 13.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.7 | 5.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.7 | 8.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.7 | 10.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.7 | 8.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.7 | 13.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.7 | 2.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.7 | 8.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.7 | 16.0 | GO:0051639 | actin filament network formation(GO:0051639) |
2.7 | 13.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
2.7 | 2.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.6 | 10.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.6 | 7.9 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
2.6 | 7.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.6 | 10.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
2.6 | 5.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.6 | 13.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.6 | 26.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
2.6 | 7.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
2.6 | 10.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.6 | 23.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
2.6 | 18.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.6 | 7.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
2.6 | 5.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.6 | 2.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.5 | 35.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
2.5 | 12.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.5 | 7.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.5 | 5.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.5 | 7.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.5 | 5.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.5 | 15.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.5 | 5.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
2.5 | 27.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.5 | 12.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.5 | 2.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
2.5 | 7.5 | GO:0060056 | mammary gland involution(GO:0060056) |
2.5 | 7.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.5 | 15.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
2.5 | 10.0 | GO:0018214 | protein carboxylation(GO:0018214) |
2.5 | 5.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.5 | 10.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
2.5 | 2.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.5 | 7.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.5 | 32.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.5 | 5.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
2.5 | 12.4 | GO:0018101 | protein citrullination(GO:0018101) |
2.5 | 2.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
2.5 | 9.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.5 | 2.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
2.5 | 7.4 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
2.5 | 14.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.5 | 9.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
2.5 | 2.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
2.4 | 12.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.4 | 12.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
2.4 | 7.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.4 | 7.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.4 | 33.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.4 | 2.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.4 | 19.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.4 | 4.8 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.4 | 4.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.4 | 12.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.4 | 2.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.4 | 7.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.4 | 7.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.4 | 9.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.4 | 7.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.4 | 9.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
2.4 | 4.7 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.4 | 7.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
2.4 | 9.4 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
2.4 | 7.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.3 | 14.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.3 | 14.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
2.3 | 4.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
2.3 | 4.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.3 | 4.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
2.3 | 18.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.3 | 14.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
2.3 | 16.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.3 | 4.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.3 | 4.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
2.3 | 9.2 | GO:0070459 | prolactin secretion(GO:0070459) |
2.3 | 13.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.3 | 11.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.3 | 4.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.3 | 4.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
2.3 | 4.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.3 | 50.2 | GO:0014823 | response to activity(GO:0014823) |
2.3 | 13.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.3 | 11.4 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
2.3 | 9.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.3 | 13.6 | GO:0097421 | liver regeneration(GO:0097421) |
2.3 | 6.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.3 | 4.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.3 | 22.6 | GO:0018904 | ether metabolic process(GO:0018904) |
2.3 | 15.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
2.2 | 4.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.2 | 6.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.2 | 2.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.2 | 15.7 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
2.2 | 6.7 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
2.2 | 2.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
2.2 | 6.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.2 | 6.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.2 | 2.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.2 | 2.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.2 | 4.4 | GO:0044026 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
2.2 | 4.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.2 | 11.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.2 | 2.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
2.2 | 8.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
2.2 | 6.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.2 | 8.7 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.2 | 4.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.2 | 4.3 | GO:1902075 | cellular response to salt(GO:1902075) |
2.2 | 6.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.2 | 6.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.2 | 4.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.1 | 4.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.1 | 25.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
2.1 | 6.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.1 | 8.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
2.1 | 2.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.1 | 10.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
2.1 | 21.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
2.1 | 10.7 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
2.1 | 4.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.1 | 6.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.1 | 12.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.1 | 12.8 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.1 | 14.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.1 | 2.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
2.1 | 8.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
2.1 | 10.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
2.1 | 12.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.1 | 8.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.1 | 46.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.1 | 12.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.1 | 6.3 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.1 | 6.3 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
2.1 | 8.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.1 | 12.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
2.1 | 25.1 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.1 | 6.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.1 | 6.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
2.1 | 18.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
2.1 | 2.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.1 | 2.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
2.1 | 2.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.1 | 12.4 | GO:0048539 | bone marrow development(GO:0048539) |
2.1 | 2.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.1 | 10.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
2.1 | 6.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.1 | 6.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.1 | 2.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.1 | 6.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.1 | 4.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.1 | 4.1 | GO:0070268 | cornification(GO:0070268) |
2.1 | 6.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.0 | 12.3 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
2.0 | 8.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.0 | 6.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.0 | 12.2 | GO:0042737 | drug catabolic process(GO:0042737) |
2.0 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.0 | 42.5 | GO:0006301 | postreplication repair(GO:0006301) |
2.0 | 6.1 | GO:0015886 | heme transport(GO:0015886) |
2.0 | 22.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.0 | 8.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.0 | 6.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.0 | 6.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
2.0 | 2.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.0 | 10.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
2.0 | 8.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
2.0 | 2.0 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.0 | 8.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.0 | 8.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.0 | 2.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.0 | 6.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
2.0 | 2.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
2.0 | 19.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.0 | 5.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.0 | 4.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.0 | 9.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.0 | 3.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
2.0 | 29.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.0 | 2.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
2.0 | 3.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.0 | 5.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.0 | 3.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.0 | 2.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.9 | 15.6 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.9 | 1.9 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.9 | 5.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.9 | 15.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.9 | 5.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.9 | 1.9 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.9 | 11.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.9 | 9.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.9 | 1.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.9 | 7.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.9 | 5.7 | GO:0015705 | iodide transport(GO:0015705) |
1.9 | 18.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.9 | 9.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.9 | 3.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.9 | 15.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.9 | 5.6 | GO:0006116 | NADH oxidation(GO:0006116) |
1.9 | 3.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.9 | 1.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.9 | 5.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.9 | 14.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.9 | 1.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.8 | 3.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.8 | 3.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.8 | 3.7 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
1.8 | 1.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
1.8 | 57.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.8 | 9.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.8 | 5.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.8 | 3.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.8 | 3.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.8 | 5.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.8 | 9.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.8 | 5.5 | GO:0001555 | oocyte growth(GO:0001555) |
1.8 | 9.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.8 | 3.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.8 | 1.8 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.8 | 5.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.8 | 1.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.8 | 9.0 | GO:0030575 | nuclear body organization(GO:0030575) |
1.8 | 5.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.8 | 3.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.8 | 5.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.8 | 5.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.8 | 7.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.8 | 12.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.8 | 1.8 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
1.8 | 5.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.8 | 5.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.8 | 8.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.8 | 7.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.8 | 7.1 | GO:0009838 | abscission(GO:0009838) |
1.8 | 7.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.8 | 10.6 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.8 | 3.5 | GO:0035973 | aggrephagy(GO:0035973) |
1.8 | 5.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.8 | 5.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.8 | 10.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.8 | 3.5 | GO:0032570 | response to progesterone(GO:0032570) |
1.8 | 1.8 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.8 | 1.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.8 | 17.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.7 | 5.2 | GO:0048102 | autophagic cell death(GO:0048102) |
1.7 | 1.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.7 | 8.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.7 | 3.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.7 | 1.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.7 | 10.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.7 | 5.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.7 | 5.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.7 | 6.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.7 | 1.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.7 | 20.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.7 | 3.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.7 | 8.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.7 | 8.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.7 | 6.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 5.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.6 | 6.6 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.6 | 14.8 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.6 | 3.3 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.6 | 1.6 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.6 | 8.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.6 | 11.4 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
1.6 | 8.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.6 | 3.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.6 | 1.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.6 | 6.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.6 | 1.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
1.6 | 3.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.6 | 1.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.6 | 3.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.6 | 1.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.6 | 6.5 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.6 | 1.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.6 | 6.4 | GO:0033227 | dsRNA transport(GO:0033227) |
1.6 | 9.7 | GO:0016266 | O-glycan processing(GO:0016266) |
1.6 | 1.6 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.6 | 3.2 | GO:0072718 | response to cisplatin(GO:0072718) |
1.6 | 1.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.6 | 1.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.6 | 3.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.6 | 8.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.6 | 3.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.6 | 3.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.6 | 6.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.6 | 7.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.6 | 7.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
1.6 | 1.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.6 | 1.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.6 | 1.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.6 | 1.6 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
1.6 | 4.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.6 | 6.3 | GO:0042168 | heme metabolic process(GO:0042168) |
1.6 | 3.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.6 | 17.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.6 | 7.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.6 | 1.6 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
1.6 | 4.7 | GO:0019532 | oxalate transport(GO:0019532) |
1.6 | 6.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.6 | 3.1 | GO:0042938 | dipeptide transport(GO:0042938) |
1.6 | 1.6 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.5 | 12.4 | GO:0046415 | urate metabolic process(GO:0046415) |
1.5 | 17.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.5 | 3.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
1.5 | 3.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 3.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.5 | 1.5 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
1.5 | 3.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.5 | 1.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.5 | 23.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.5 | 3.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.5 | 3.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.5 | 6.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.5 | 4.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.5 | 9.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.5 | 1.5 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
1.5 | 4.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.5 | 19.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.5 | 3.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.5 | 7.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.5 | 6.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.5 | 1.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
1.5 | 3.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.5 | 3.0 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.5 | 10.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.5 | 6.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.5 | 1.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.5 | 6.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
1.5 | 3.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
1.5 | 7.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.5 | 20.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.5 | 4.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.5 | 10.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.5 | 1.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.5 | 3.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.5 | 1.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.5 | 17.7 | GO:0045116 | protein neddylation(GO:0045116) |
1.5 | 14.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.5 | 11.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.5 | 2.9 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
1.5 | 5.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.5 | 1.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.4 | 2.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.4 | 1.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.4 | 4.3 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
1.4 | 4.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.4 | 7.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.4 | 4.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.4 | 1.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.4 | 1.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
1.4 | 2.9 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.4 | 17.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.4 | 12.8 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
1.4 | 7.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.4 | 11.4 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.4 | 1.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.4 | 4.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.4 | 4.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.4 | 2.8 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.4 | 11.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.4 | 2.8 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.4 | 5.6 | GO:0016264 | gap junction assembly(GO:0016264) |
1.4 | 7.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.4 | 2.8 | GO:0035799 | ureter maturation(GO:0035799) |
1.4 | 2.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.4 | 1.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
1.4 | 12.5 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
1.4 | 6.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.4 | 23.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.4 | 13.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
1.4 | 6.9 | GO:0050779 | RNA destabilization(GO:0050779) |
1.4 | 1.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.4 | 2.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
1.4 | 9.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.4 | 9.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.4 | 5.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.4 | 5.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.4 | 6.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.4 | 4.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
1.4 | 9.5 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
1.3 | 1.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.3 | 4.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.3 | 6.7 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
1.3 | 12.1 | GO:0051156 | pentose-phosphate shunt(GO:0006098) glucose 6-phosphate metabolic process(GO:0051156) |
1.3 | 6.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.3 | 1.3 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
1.3 | 6.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.3 | 9.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.3 | 10.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.3 | 8.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.3 | 4.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.3 | 2.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.3 | 4.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.3 | 4.0 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
1.3 | 5.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.3 | 4.0 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
1.3 | 10.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.3 | 4.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.3 | 3.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.3 | 2.6 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.3 | 3.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.3 | 9.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.3 | 3.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 3.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.3 | 2.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.3 | 1.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.3 | 1.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.3 | 9.1 | GO:0009299 | mRNA transcription(GO:0009299) |
1.3 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.3 | 9.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
1.3 | 9.0 | GO:0046697 | decidualization(GO:0046697) |
1.3 | 33.4 | GO:0006094 | gluconeogenesis(GO:0006094) |
1.3 | 10.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.3 | 5.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.3 | 1.3 | GO:0061724 | lipophagy(GO:0061724) |
1.3 | 5.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.3 | 6.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.3 | 1.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.3 | 14.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.3 | 1.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.3 | 6.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.3 | 1.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.3 | 3.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.3 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.3 | 5.1 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
1.3 | 8.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.3 | 6.3 | GO:0070986 | left/right axis specification(GO:0070986) |
1.3 | 3.8 | GO:0075522 | viral translation(GO:0019081) IRES-dependent viral translational initiation(GO:0075522) |
1.3 | 5.0 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.3 | 3.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.2 | 2.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.2 | 18.7 | GO:0048821 | erythrocyte development(GO:0048821) |
1.2 | 6.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.2 | 2.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
1.2 | 3.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.2 | 11.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
1.2 | 7.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.2 | 8.7 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
1.2 | 3.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 21.0 | GO:0034340 | response to type I interferon(GO:0034340) |
1.2 | 4.9 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.2 | 6.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.2 | 2.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 3.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.2 | 6.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.2 | 3.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.2 | 7.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.2 | 1.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.2 | 2.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.2 | 10.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
1.2 | 6.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.2 | 10.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.2 | 3.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.2 | 2.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.2 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 12.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.2 | 12.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.2 | 13.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.2 | 1.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.2 | 15.5 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.2 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.2 | 2.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.2 | 6.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.2 | 3.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.2 | 3.6 | GO:0015889 | cobalamin transport(GO:0015889) |
1.2 | 7.1 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 9.5 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
1.2 | 1.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
1.2 | 2.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.2 | 13.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
1.2 | 4.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.2 | 23.5 | GO:0031648 | protein destabilization(GO:0031648) |
1.2 | 24.6 | GO:0043297 | apical junction assembly(GO:0043297) |
1.2 | 9.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.2 | 4.7 | GO:0060613 | fat pad development(GO:0060613) |
1.2 | 4.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.2 | 11.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.2 | 2.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.2 | 5.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.2 | 2.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
1.2 | 3.5 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.2 | 6.9 | GO:0030033 | microvillus assembly(GO:0030033) |
1.2 | 8.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.1 | 3.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.1 | 2.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.1 | 4.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.1 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 12.6 | GO:0048535 | lymph node development(GO:0048535) |
1.1 | 9.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
1.1 | 3.4 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.1 | 1.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.1 | 4.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.1 | 1.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.1 | 7.9 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.1 | 4.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.1 | 3.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.1 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.1 | 1.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
1.1 | 6.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.1 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.1 | 2.2 | GO:1903416 | response to glycoside(GO:1903416) |
1.1 | 3.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
1.1 | 16.8 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.1 | 6.7 | GO:0035878 | nail development(GO:0035878) |
1.1 | 31.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
1.1 | 32.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.1 | 3.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.1 | 7.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.1 | 2.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.1 | 5.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.1 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.1 | 7.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 1.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.1 | 3.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 3.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.1 | 3.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.1 | 5.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.1 | 5.4 | GO:0007097 | nuclear migration(GO:0007097) |
1.1 | 3.3 | GO:0000012 | single strand break repair(GO:0000012) |
1.1 | 6.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.1 | 25.0 | GO:0016925 | protein sumoylation(GO:0016925) |
1.1 | 2.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.1 | 3.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.1 | 1.1 | GO:0010159 | specification of organ position(GO:0010159) |
1.1 | 6.5 | GO:0032060 | bleb assembly(GO:0032060) |
1.1 | 1.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.1 | 2.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.1 | 6.5 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
1.1 | 1.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.1 | 11.8 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
1.1 | 4.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.1 | 1.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
1.1 | 2.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.1 | 2.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
1.1 | 11.8 | GO:0006828 | manganese ion transport(GO:0006828) |
1.1 | 7.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.1 | 3.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.1 | 1.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.1 | 2.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.1 | 3.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.1 | 3.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.1 | 8.5 | GO:0002327 | immature B cell differentiation(GO:0002327) |
1.1 | 25.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.1 | 7.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.0 | 1.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.0 | 2.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.0 | 15.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.0 | 4.2 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
1.0 | 3.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.0 | 27.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
1.0 | 4.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.0 | 1.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
1.0 | 3.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.0 | 3.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.0 | 10.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.0 | 1.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.0 | 3.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.0 | 7.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
1.0 | 1.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.0 | 1.0 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.0 | 4.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 4.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.0 | 4.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
1.0 | 4.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.0 | 1.0 | GO:0048382 | mesendoderm development(GO:0048382) |
1.0 | 38.5 | GO:0007569 | cell aging(GO:0007569) |
1.0 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 1.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.0 | 6.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 3.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.0 | 6.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
1.0 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.0 | 1.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
1.0 | 6.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.0 | 9.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.0 | 2.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.0 | 1.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.0 | 2.0 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 10.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.0 | 9.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.0 | 2.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.0 | 2.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.0 | 1.0 | GO:0015755 | fructose transport(GO:0015755) |
1.0 | 25.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.0 | 90.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
1.0 | 1.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.0 | 2.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 1.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.0 | 8.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.0 | 2.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.0 | 8.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.0 | 2.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.0 | 1.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.0 | 5.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.0 | 1.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.0 | 1.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.0 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 4.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.0 | 5.7 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.9 | 1.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.9 | 4.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 1.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 3.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 7.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.9 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.9 | 4.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.9 | 0.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.9 | 1.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.9 | 2.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.9 | 3.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.9 | 4.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.9 | 4.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.9 | 0.9 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.9 | 2.8 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.9 | 0.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.9 | 5.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.9 | 10.2 | GO:0002385 | mucosal immune response(GO:0002385) |
0.9 | 3.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.9 | 0.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 2.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.9 | 3.7 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.9 | 4.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.9 | 8.3 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.9 | 6.4 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.9 | 18.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.9 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.9 | 4.6 | GO:0001774 | microglial cell activation(GO:0001774) |
0.9 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 3.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 2.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.9 | 3.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.9 | 0.9 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.9 | 6.3 | GO:0007379 | segment specification(GO:0007379) |
0.9 | 0.9 | GO:0060157 | urinary bladder development(GO:0060157) |
0.9 | 5.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.9 | 1.8 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.9 | 2.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 5.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.9 | 1.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.9 | 0.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.9 | 1.8 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.9 | 0.9 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.9 | 1.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.9 | 1.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.9 | 2.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.9 | 6.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.9 | 0.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 11.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.9 | 1.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.9 | 6.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.9 | 0.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.9 | 3.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.9 | 1.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 13.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.9 | 1.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.9 | 4.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.9 | 2.6 | GO:0036035 | osteoclast development(GO:0036035) |
0.9 | 6.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.9 | 7.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 1.7 | GO:0030539 | male genitalia development(GO:0030539) |
0.9 | 4.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.9 | 2.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.9 | 0.9 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.9 | 0.9 | GO:0019042 | viral latency(GO:0019042) |
0.9 | 3.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.9 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 2.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 0.8 | GO:0090330 | regulation of platelet aggregation(GO:0090330) |
0.8 | 8.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.8 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.8 | 6.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.8 | 1.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.8 | 1.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.8 | 3.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.8 | 0.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.8 | 5.8 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 2.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 3.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 3.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.8 | 6.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.8 | 4.9 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.8 | 3.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 6.5 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.8 | 2.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.8 | 11.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.8 | 9.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.8 | 3.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 2.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.8 | 2.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.8 | 6.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.8 | 18.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.8 | 2.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.8 | 1.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.8 | 2.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 1.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.8 | 2.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.8 | 6.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.8 | 6.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 4.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.8 | 1.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.8 | 3.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 2.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.8 | 0.8 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.8 | 5.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.8 | 15.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.8 | 3.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.8 | 4.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.8 | 5.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.8 | 2.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.8 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.8 | 2.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.8 | 3.9 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.8 | 1.5 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.8 | 6.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.8 | 5.4 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.8 | 1.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.8 | 1.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 0.8 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.8 | 22.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.8 | 5.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.8 | 2.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.8 | 1.5 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.7 | 4.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.7 | 3.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 0.7 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.7 | 1.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.7 | 4.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 3.0 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.7 | 7.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.7 | 0.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.7 | 5.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 25.8 | GO:0006956 | complement activation(GO:0006956) |
0.7 | 0.7 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.7 | 10.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.7 | 5.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.7 | 0.7 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.7 | 2.2 | GO:0015669 | gas transport(GO:0015669) one-carbon compound transport(GO:0019755) |
0.7 | 3.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.7 | 10.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.7 | 12.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 7.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 1.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 2.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.7 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.7 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 1.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.7 | 1.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 0.7 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.7 | 2.8 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.7 | 2.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 4.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.7 | 9.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.7 | 0.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.7 | 2.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 3.5 | GO:0009650 | UV protection(GO:0009650) |
0.7 | 0.7 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 2.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.7 | 1.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 0.7 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.7 | 4.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.7 | 5.5 | GO:0006415 | translational termination(GO:0006415) |
0.7 | 0.7 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 1.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.7 | 2.7 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.7 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.7 | 0.7 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.7 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 1.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.7 | 5.4 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.7 | 8.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.7 | 2.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.7 | 0.7 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.7 | 2.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 1.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.7 | 3.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 8.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.7 | 0.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.7 | 2.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.7 | 0.7 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.7 | 2.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.7 | 2.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.7 | 1.3 | GO:0072376 | protein activation cascade(GO:0072376) |
0.7 | 8.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 7.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.7 | 1.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.7 | 4.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.7 | 0.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 1.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.7 | 7.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.7 | 1.3 | GO:0061440 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) |
0.7 | 3.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 1.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 4.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.6 | 13.0 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) |
0.6 | 3.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.9 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.6 | 1.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.6 | 2.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.6 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.6 | 1.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 0.6 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.6 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.6 | 6.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.6 | 0.6 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.6 | 1.3 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.6 | 0.6 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.6 | 2.5 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.6 | 1.9 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.6 | 7.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.6 | 1.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 2.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 3.2 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.6 | 15.1 | GO:0031424 | keratinization(GO:0031424) |
0.6 | 1.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 6.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.6 | 1.9 | GO:0015809 | arginine transport(GO:0015809) |
0.6 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 0.6 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.6 | 7.5 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.6 | 0.6 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.6 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 3.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 1.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.6 | 1.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.6 | 5.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.6 | 0.6 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.6 | 5.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 1.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.6 | 4.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 1.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.6 | 0.6 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.6 | 0.6 | GO:0042998 | regulation of Golgi to plasma membrane protein transport(GO:0042996) positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.6 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 0.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.6 | 0.6 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.6 | 8.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.6 | 2.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.6 | 2.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 1.2 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.6 | 13.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.6 | 1.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.6 | 1.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.6 | 2.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 1.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.6 | 7.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.6 | 11.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.6 | 4.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.6 | 20.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.6 | 5.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.6 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.6 | 0.6 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.6 | 1.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.6 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 2.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 0.6 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.6 | 2.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
0.6 | 1.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 0.6 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.6 | 6.8 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.6 | 1.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.6 | 1.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 1.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.6 | 1.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.6 | 2.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.6 | 0.6 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.6 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.6 | 1.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.5 | 2.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.5 | 2.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 1.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 1.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 3.8 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.5 | 11.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.5 | 6.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 6.5 | GO:0051168 | nuclear export(GO:0051168) |
0.5 | 2.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.5 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.5 | 1.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 2.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.5 | 0.5 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.5 | 4.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 1.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 0.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.5 | 0.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.5 | 1.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.5 | 1.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.5 | 4.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.5 | 1.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.5 | 1.0 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.5 | 8.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.5 | 2.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 1.6 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.5 | 8.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.5 | 2.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.5 | 2.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.5 | 1.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 1.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 1.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.5 | 3.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.5 | 2.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.5 | 2.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.5 | 2.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 0.5 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.5 | 10.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.5 | 1.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.5 | 2.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.5 | 1.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.5 | 2.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.5 | 3.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 1.0 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 5.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 3.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.5 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 1.0 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) |
0.5 | 4.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.5 | 1.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.5 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.5 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.5 | 2.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 1.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 0.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.5 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.5 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 0.5 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
0.5 | 2.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.5 | 1.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.5 | 1.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 | 3.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 3.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.5 | 1.9 | GO:0048536 | spleen development(GO:0048536) |
0.5 | 1.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.5 | 0.5 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.5 | 2.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.5 | 2.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 22.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 1.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.5 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.5 | 3.7 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.5 | 1.4 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.5 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 0.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.5 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 0.5 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.5 | 0.9 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 2.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 0.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 13.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 0.9 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.5 | 0.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 11.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 1.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.5 | 4.5 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.5 | 5.4 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.5 | 0.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.4 | 1.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.4 | 3.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.4 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 6.3 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.4 | 0.9 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 6.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.4 | 2.6 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.4 | 2.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 2.2 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 1.7 | GO:0070071 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.4 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.4 | 3.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.4 | 2.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.4 | 0.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 14.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 2.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 1.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 0.4 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.4 | 3.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 21.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 1.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 2.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 3.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 0.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 1.7 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.4 | 0.4 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.4 | 5.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.4 | 4.2 | GO:0048753 | pigment granule organization(GO:0048753) |
0.4 | 6.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 0.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.4 | 2.9 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 0.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 0.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.4 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.4 | 4.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.4 | 2.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 0.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 | 0.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.4 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.4 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 0.8 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.4 | 3.5 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.4 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.4 | 2.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 0.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.4 | 1.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 2.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.4 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 2.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.4 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 2.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 4.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.4 | 0.7 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.4 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 0.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 2.9 | GO:0007099 | centriole replication(GO:0007099) |
0.4 | 2.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 0.7 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.4 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.4 | 6.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 4.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 7.3 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 4.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 14.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 1.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 1.0 | GO:0001759 | organ induction(GO:0001759) |
0.3 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 3.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 4.3 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 3.0 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.7 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.3 | 1.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 2.6 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.3 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 4.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 1.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 0.3 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
0.3 | 0.6 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 2.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 2.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 5.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 0.6 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.3 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.3 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 2.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.3 | 2.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 1.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 7.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.3 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.3 | 1.2 | GO:0017004 | cytochrome complex assembly(GO:0017004) respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.3 | 10.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 2.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.3 | 2.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 0.9 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.3 | 3.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 9.8 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.3 | 4.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 2.0 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 2.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 0.6 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.3 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 5.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.3 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 0.6 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 6.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 1.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.3 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 1.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 4.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 0.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.5 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 2.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 1.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 1.0 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 2.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.2 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 1.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 7.1 | GO:0007596 | blood coagulation(GO:0007596) |
0.2 | 0.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 2.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.7 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.2 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.2 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 4.3 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 9.7 | GO:0006310 | DNA recombination(GO:0006310) |
0.2 | 1.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 1.5 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.2 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 1.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 5.8 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 4.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.2 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 7.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.8 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 1.8 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 1.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 3.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 2.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.6 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.2 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 1.7 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.2 | 2.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 10.9 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.2 | 1.6 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.3 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 1.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 1.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 4.2 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.3 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 4.5 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 4.1 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 2.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 6.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 1.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.7 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 21.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 8.4 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 8.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 1.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 3.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 1.1 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 2.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 3.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 4.9 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 1.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0043470 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.3 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.5 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 6.3 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.0 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 42.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
8.1 | 24.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
7.3 | 22.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
6.3 | 25.3 | GO:0072487 | MSL complex(GO:0072487) |
6.1 | 18.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
5.6 | 33.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
5.2 | 20.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
5.0 | 29.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.7 | 37.7 | GO:0030056 | hemidesmosome(GO:0030056) |
4.4 | 17.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
4.3 | 21.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.2 | 12.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
4.2 | 21.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
4.1 | 16.3 | GO:1990357 | terminal web(GO:1990357) |
4.0 | 23.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
4.0 | 11.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.9 | 11.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.6 | 50.8 | GO:0031528 | microvillus membrane(GO:0031528) |
3.5 | 14.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.5 | 13.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.5 | 13.9 | GO:0005642 | annulate lamellae(GO:0005642) |
3.5 | 17.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
3.5 | 10.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
3.4 | 17.0 | GO:0005638 | lamin filament(GO:0005638) |
3.4 | 27.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
3.4 | 13.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.4 | 10.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
3.2 | 3.2 | GO:0016939 | kinesin II complex(GO:0016939) |
3.2 | 3.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
3.2 | 9.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.1 | 3.1 | GO:0071953 | elastic fiber(GO:0071953) |
3.0 | 6.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.9 | 11.5 | GO:0042825 | TAP complex(GO:0042825) |
2.9 | 20.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.9 | 11.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.9 | 8.6 | GO:1990635 | proximal dendrite(GO:1990635) |
2.8 | 30.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.8 | 8.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.8 | 41.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.8 | 19.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
2.8 | 19.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.7 | 10.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.7 | 13.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.7 | 26.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.6 | 10.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.6 | 18.2 | GO:0042382 | paraspeckles(GO:0042382) |
2.5 | 5.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.5 | 7.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.5 | 7.4 | GO:0031523 | Myb complex(GO:0031523) |
2.5 | 27.0 | GO:0035102 | PRC1 complex(GO:0035102) |
2.5 | 34.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.4 | 7.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.4 | 2.4 | GO:0043219 | lateral loop(GO:0043219) |
2.4 | 140.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.4 | 4.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.4 | 16.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.3 | 7.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.3 | 11.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.3 | 6.9 | GO:0097452 | GAIT complex(GO:0097452) |
2.3 | 18.4 | GO:0001650 | fibrillar center(GO:0001650) |
2.3 | 47.6 | GO:0000786 | nucleosome(GO:0000786) |
2.3 | 22.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.2 | 6.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.2 | 6.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.2 | 11.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.2 | 96.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.2 | 8.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
2.2 | 8.7 | GO:0035363 | histone locus body(GO:0035363) |
2.2 | 10.8 | GO:0031983 | vesicle lumen(GO:0031983) |
2.1 | 17.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.1 | 6.3 | GO:0005915 | zonula adherens(GO:0005915) |
2.1 | 18.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
2.1 | 8.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.1 | 20.9 | GO:0070938 | contractile ring(GO:0070938) |
2.1 | 12.5 | GO:0090543 | Flemming body(GO:0090543) |
2.1 | 6.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
2.0 | 6.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.0 | 22.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
2.0 | 6.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.0 | 6.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.0 | 6.0 | GO:0097413 | Lewy body(GO:0097413) |
2.0 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
2.0 | 9.9 | GO:0044194 | cytolytic granule(GO:0044194) |
2.0 | 9.8 | GO:0030914 | STAGA complex(GO:0030914) |
1.9 | 5.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.9 | 7.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.9 | 21.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.9 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.9 | 5.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.9 | 1.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.9 | 28.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.9 | 5.6 | GO:0097443 | sorting endosome(GO:0097443) |
1.9 | 38.9 | GO:0045120 | pronucleus(GO:0045120) |
1.8 | 16.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.8 | 10.8 | GO:0031415 | NatA complex(GO:0031415) |
1.8 | 17.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.8 | 5.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.8 | 7.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.8 | 19.6 | GO:0032039 | integrator complex(GO:0032039) |
1.8 | 14.1 | GO:0005861 | troponin complex(GO:0005861) |
1.8 | 8.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.7 | 8.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.7 | 13.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.7 | 12.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.7 | 5.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.7 | 5.1 | GO:1990423 | RZZ complex(GO:1990423) |
1.7 | 18.6 | GO:0002102 | podosome(GO:0002102) |
1.7 | 6.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.7 | 5.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.7 | 48.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.6 | 11.5 | GO:0097470 | ribbon synapse(GO:0097470) |
1.6 | 13.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.6 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 91.2 | GO:0032432 | actin filament bundle(GO:0032432) |
1.6 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.6 | 3.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.6 | 8.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.6 | 1.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.6 | 3.2 | GO:0005914 | spot adherens junction(GO:0005914) |
1.6 | 6.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.6 | 6.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.6 | 12.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.6 | 20.5 | GO:0038201 | TOR complex(GO:0038201) |
1.6 | 142.0 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 7.9 | GO:0005657 | replication fork(GO:0005657) |
1.6 | 14.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.6 | 1.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.5 | 60.8 | GO:0045095 | keratin filament(GO:0045095) |
1.5 | 4.5 | GO:1990923 | PET complex(GO:1990923) |
1.5 | 4.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 7.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.5 | 4.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.5 | 4.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.5 | 4.4 | GO:0043293 | apoptosome(GO:0043293) |
1.5 | 4.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.5 | 5.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.4 | 4.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.4 | 7.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.4 | 10.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.4 | 11.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.4 | 110.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.4 | 38.5 | GO:0016592 | mediator complex(GO:0016592) |
1.4 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.4 | 40.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.4 | 28.0 | GO:0008305 | integrin complex(GO:0008305) |
1.4 | 9.8 | GO:0042641 | actomyosin(GO:0042641) |
1.4 | 13.9 | GO:0061702 | inflammasome complex(GO:0061702) |
1.4 | 6.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.4 | 24.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.4 | 4.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.4 | 4.1 | GO:0000811 | GINS complex(GO:0000811) |
1.4 | 6.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.4 | 1.4 | GO:1903349 | omegasome membrane(GO:1903349) |
1.3 | 8.1 | GO:0042587 | glycogen granule(GO:0042587) |
1.3 | 12.1 | GO:0010369 | chromocenter(GO:0010369) |
1.3 | 4.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.3 | 4.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.3 | 12.1 | GO:0090544 | BAF-type complex(GO:0090544) |
1.3 | 10.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.3 | 128.9 | GO:0005903 | brush border(GO:0005903) |
1.3 | 4.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.3 | 5.3 | GO:0030689 | Noc complex(GO:0030689) |
1.3 | 13.2 | GO:0005776 | autophagosome(GO:0005776) |
1.3 | 6.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.3 | 3.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.3 | 10.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.3 | 13.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.3 | 1.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.3 | 10.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.3 | 3.8 | GO:0035061 | interchromatin granule(GO:0035061) |
1.3 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
1.3 | 1.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.3 | 5.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.3 | 23.8 | GO:0000242 | pericentriolar material(GO:0000242) |
1.3 | 2.5 | GO:1990462 | omegasome(GO:1990462) |
1.3 | 5.0 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.3 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.2 | 3.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 1.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
1.2 | 8.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.2 | 7.4 | GO:0005818 | aster(GO:0005818) |
1.2 | 3.7 | GO:0005688 | U6 snRNP(GO:0005688) |
1.2 | 3.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.2 | 56.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.2 | 11.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.2 | 2.4 | GO:0030870 | Mre11 complex(GO:0030870) |
1.2 | 2.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.2 | 8.3 | GO:0071439 | clathrin complex(GO:0071439) |
1.2 | 60.6 | GO:0016605 | PML body(GO:0016605) |
1.2 | 23.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.2 | 50.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.2 | 17.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
1.1 | 21.8 | GO:0051233 | spindle midzone(GO:0051233) |
1.1 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.1 | 3.4 | GO:0098536 | deuterosome(GO:0098536) |
1.1 | 1.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.1 | 13.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.1 | 15.6 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.1 | 1.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.1 | 141.6 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 6.7 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 3.3 | GO:0031902 | late endosome membrane(GO:0031902) |
1.1 | 55.1 | GO:0016363 | nuclear matrix(GO:0016363) |
1.1 | 5.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.1 | 19.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.1 | 9.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.1 | 4.3 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 3.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
1.1 | 11.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.1 | 19.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.0 | 2.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 1.0 | GO:0042585 | germinal vesicle(GO:0042585) |
1.0 | 5.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.0 | 3.1 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 3.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.0 | 6.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 15.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.0 | 13.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.0 | 4.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.0 | 6.1 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 44.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.0 | 13.1 | GO:0036038 | MKS complex(GO:0036038) |
1.0 | 3.0 | GO:1990130 | Iml1 complex(GO:1990130) |
1.0 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
1.0 | 3.0 | GO:0035861 | site of double-strand break(GO:0035861) |
1.0 | 9.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.0 | 4.0 | GO:0005827 | polar microtubule(GO:0005827) |
1.0 | 8.9 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 4.9 | GO:0005683 | U7 snRNP(GO:0005683) |
1.0 | 23.5 | GO:0097228 | sperm principal piece(GO:0097228) |
1.0 | 22.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.0 | 44.9 | GO:0005811 | lipid particle(GO:0005811) |
1.0 | 7.8 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.0 | 7.8 | GO:0042581 | specific granule(GO:0042581) |
1.0 | 2.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 3.9 | GO:0097255 | R2TP complex(GO:0097255) |
1.0 | 20.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
1.0 | 8.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 8.7 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 3.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.9 | 7.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 7.6 | GO:0046930 | pore complex(GO:0046930) |
0.9 | 5.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.9 | 41.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.9 | 2.8 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.9 | 15.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.9 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 7.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 7.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.9 | 2.8 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 2.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.9 | 2.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.9 | 3.7 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.9 | 3.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.9 | 3.6 | GO:0000243 | commitment complex(GO:0000243) |
0.9 | 6.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.9 | 3.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 1.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.9 | 111.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.9 | 20.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.9 | 9.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.9 | 2.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.9 | 1.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.9 | 4.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.9 | 5.1 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 4.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.8 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.8 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.8 | 7.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.8 | 3.3 | GO:1990745 | EARP complex(GO:1990745) |
0.8 | 8.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 15.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.8 | 3.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 7.4 | GO:0030057 | desmosome(GO:0030057) |
0.8 | 8.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 8.9 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 0.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.8 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 18.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.8 | 4.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.8 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.8 | 3.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.8 | 2.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 3.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.8 | 11.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 32.7 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.8 | 3.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.8 | 2.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.8 | 9.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.8 | 6.8 | GO:0032797 | SMN complex(GO:0032797) |
0.8 | 3.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 17.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 943.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.7 | 4.4 | GO:0042599 | lamellar body(GO:0042599) |
0.7 | 50.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.7 | 5.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 78.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.7 | 1.4 | GO:0016234 | inclusion body(GO:0016234) |
0.7 | 15.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 4.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 20.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.7 | 30.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.7 | 1.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 2.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 7.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.7 | 7.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.7 | 2.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 6.0 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.7 | 8.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.7 | 2.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.7 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.7 | 32.5 | GO:0000776 | kinetochore(GO:0000776) |
0.6 | 113.0 | GO:0005694 | chromosome(GO:0005694) |
0.6 | 3.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 7.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 5.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 20.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 10.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 112.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.6 | 15.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.6 | 4.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 1.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.6 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 1.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 13.8 | GO:0005938 | cell cortex(GO:0005938) |
0.6 | 2.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 34.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 7.0 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 23.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 4.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 31.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.5 | 6.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.5 | 15.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 3.5 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 2.0 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.5 | 1.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 9.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 132.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.5 | 2.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.5 | 14.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.5 | 7.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 19.0 | GO:0005814 | centriole(GO:0005814) |
0.5 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 4.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.5 | 12.8 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 4.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 131.5 | GO:0005730 | nucleolus(GO:0005730) |
0.5 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 2.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 5.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 564.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 0.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 2.7 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 15.9 | GO:0031514 | motile cilium(GO:0031514) |
0.4 | 3.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 5.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 4.8 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 3.7 | GO:0005844 | polysome(GO:0005844) |
0.3 | 5.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 4.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 137.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 3.0 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 7.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 10.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 10.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 40.2 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 2.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 27.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
9.0 | 27.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
7.3 | 21.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
7.2 | 7.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
6.9 | 27.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
6.4 | 19.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
6.4 | 6.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
6.1 | 18.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
6.1 | 36.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
5.9 | 29.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
5.8 | 23.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
5.4 | 16.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
5.3 | 47.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
5.2 | 36.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
5.2 | 20.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
5.1 | 15.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
5.0 | 40.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
5.0 | 19.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.9 | 19.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
4.7 | 14.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
4.6 | 9.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.5 | 18.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.5 | 13.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
4.5 | 13.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.5 | 4.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
4.4 | 21.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
4.2 | 12.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
4.1 | 12.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
4.1 | 16.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
4.1 | 12.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
4.0 | 16.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.9 | 15.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
3.9 | 11.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
3.8 | 11.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.7 | 11.2 | GO:1990188 | euchromatin binding(GO:1990188) |
3.7 | 14.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.7 | 25.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
3.7 | 66.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
3.7 | 11.1 | GO:0048030 | disaccharide binding(GO:0048030) |
3.7 | 14.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
3.7 | 25.6 | GO:0005113 | patched binding(GO:0005113) |
3.6 | 32.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
3.6 | 14.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
3.5 | 10.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.5 | 3.5 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
3.5 | 13.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.4 | 17.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
3.3 | 20.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.3 | 16.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
3.3 | 9.9 | GO:0050692 | DBD domain binding(GO:0050692) |
3.3 | 23.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.3 | 52.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.3 | 9.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.2 | 42.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
3.2 | 9.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.2 | 12.8 | GO:0043515 | kinetochore binding(GO:0043515) |
3.2 | 16.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.2 | 12.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
3.2 | 15.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
3.2 | 12.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.1 | 34.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
3.1 | 9.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
3.1 | 9.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
3.1 | 24.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.1 | 6.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
3.0 | 12.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
3.0 | 15.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
3.0 | 9.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.0 | 9.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.0 | 11.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
3.0 | 8.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.9 | 17.7 | GO:0016936 | galactoside binding(GO:0016936) |
2.9 | 14.6 | GO:0031013 | troponin I binding(GO:0031013) |
2.9 | 8.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.9 | 11.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.9 | 63.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.9 | 14.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.9 | 31.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
2.9 | 2.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.8 | 5.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.8 | 8.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
2.8 | 59.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.8 | 11.3 | GO:0034618 | arginine binding(GO:0034618) |
2.8 | 42.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.8 | 25.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.8 | 8.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.8 | 64.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.7 | 22.0 | GO:0017166 | vinculin binding(GO:0017166) |
2.7 | 19.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.7 | 8.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.7 | 13.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
2.7 | 13.5 | GO:0070061 | fructose binding(GO:0070061) |
2.7 | 5.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
2.6 | 10.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
2.6 | 13.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.6 | 10.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.6 | 2.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.6 | 7.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
2.6 | 10.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.6 | 18.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.6 | 39.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
2.6 | 2.6 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
2.6 | 7.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.5 | 76.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.5 | 7.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.5 | 32.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.5 | 2.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
2.5 | 30.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.5 | 12.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.5 | 7.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
2.5 | 9.8 | GO:0042731 | PH domain binding(GO:0042731) |
2.5 | 7.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.4 | 12.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.4 | 12.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.4 | 21.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
2.4 | 9.6 | GO:0009374 | biotin binding(GO:0009374) |
2.4 | 7.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.4 | 9.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
2.4 | 35.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.4 | 18.8 | GO:0008430 | selenium binding(GO:0008430) |
2.3 | 16.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.3 | 11.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.3 | 14.0 | GO:0038132 | neuregulin binding(GO:0038132) |
2.3 | 7.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.3 | 13.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.3 | 4.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.3 | 6.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.3 | 9.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
2.3 | 25.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
2.3 | 6.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.2 | 13.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
2.2 | 46.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.2 | 4.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.2 | 8.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.2 | 8.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.2 | 4.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.2 | 11.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.2 | 6.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 8.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.2 | 4.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.1 | 4.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.1 | 8.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.1 | 2.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
2.1 | 10.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.1 | 8.5 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.1 | 19.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.1 | 10.6 | GO:0015288 | porin activity(GO:0015288) |
2.1 | 23.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.1 | 18.8 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.1 | 10.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.1 | 29.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.1 | 6.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.1 | 16.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.0 | 6.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 14.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.0 | 8.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.0 | 6.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.0 | 14.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.0 | 30.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.0 | 8.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.0 | 2.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
2.0 | 34.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.0 | 6.0 | GO:0004359 | glutaminase activity(GO:0004359) |
2.0 | 10.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.0 | 4.0 | GO:0030519 | snoRNP binding(GO:0030519) |
2.0 | 19.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.0 | 9.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 9.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.0 | 7.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
2.0 | 7.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.0 | 13.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
2.0 | 3.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.0 | 11.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.9 | 7.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 3.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.9 | 9.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.9 | 7.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.9 | 7.7 | GO:0015232 | heme transporter activity(GO:0015232) |
1.9 | 3.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.9 | 17.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.9 | 28.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.9 | 11.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.9 | 9.4 | GO:0034046 | poly(G) binding(GO:0034046) |
1.9 | 3.7 | GO:0015928 | fucosidase activity(GO:0015928) |
1.9 | 13.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.9 | 7.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.8 | 7.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.8 | 1.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.8 | 7.4 | GO:0030984 | kininogen binding(GO:0030984) |
1.8 | 9.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.8 | 5.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.8 | 7.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.8 | 12.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.8 | 7.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 3.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.8 | 3.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.8 | 7.1 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
1.8 | 3.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.8 | 1.8 | GO:0035173 | histone kinase activity(GO:0035173) |
1.7 | 17.5 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.7 | 1.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.7 | 12.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.7 | 1.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.7 | 6.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.7 | 1.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.7 | 30.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.7 | 5.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.7 | 6.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.7 | 6.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.7 | 23.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.7 | 8.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.7 | 5.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.7 | 40.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.7 | 16.7 | GO:0001846 | opsonin binding(GO:0001846) |
1.7 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.7 | 6.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.6 | 4.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.6 | 23.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.6 | 3.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
1.6 | 14.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.6 | 13.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.6 | 4.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.6 | 3.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.6 | 19.5 | GO:0008143 | poly(A) binding(GO:0008143) |
1.6 | 3.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.6 | 3.2 | GO:0004103 | choline kinase activity(GO:0004103) |
1.6 | 12.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.6 | 30.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.6 | 14.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.6 | 1.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.6 | 14.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.6 | 4.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.6 | 4.7 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.6 | 4.7 | GO:0043199 | sulfate binding(GO:0043199) |
1.6 | 4.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.6 | 4.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.6 | 14.0 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.6 | 10.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.5 | 10.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.5 | 1.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
1.5 | 1.5 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.5 | 6.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.5 | 7.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.5 | 9.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.5 | 6.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.5 | 6.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.5 | 10.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.5 | 13.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.5 | 4.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 18.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.5 | 6.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.5 | 30.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.5 | 3.0 | GO:0051870 | methotrexate binding(GO:0051870) |
1.5 | 16.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.5 | 12.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.5 | 4.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.5 | 12.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.5 | 12.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.5 | 9.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.5 | 3.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.5 | 7.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.5 | 1.5 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
1.5 | 32.6 | GO:0045296 | cadherin binding(GO:0045296) |
1.5 | 11.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.5 | 7.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.5 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.5 | 8.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.5 | 59.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.5 | 20.3 | GO:0001618 | virus receptor activity(GO:0001618) |
1.4 | 14.4 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.4 | 11.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.4 | 11.4 | GO:0031996 | thioesterase binding(GO:0031996) |
1.4 | 5.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
1.4 | 4.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.4 | 7.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.4 | 14.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.4 | 8.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.4 | 5.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.4 | 8.4 | GO:0000182 | rDNA binding(GO:0000182) |
1.4 | 1.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.4 | 15.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.4 | 15.3 | GO:0005123 | death receptor binding(GO:0005123) |
1.4 | 6.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 4.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.4 | 34.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.4 | 9.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.4 | 2.8 | GO:0055100 | adiponectin binding(GO:0055100) |
1.4 | 4.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.4 | 6.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.4 | 12.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.4 | 1.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) inositol trisphosphate kinase activity(GO:0051766) |
1.4 | 10.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.4 | 12.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.3 | 5.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.3 | 5.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.3 | 4.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.3 | 10.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 4.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 37.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.3 | 2.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.3 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 6.6 | GO:0008199 | ferric iron binding(GO:0008199) |
1.3 | 4.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.3 | 3.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.3 | 6.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.3 | 1.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.3 | 14.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.3 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.3 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.3 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.3 | 3.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.3 | 28.2 | GO:0043236 | laminin binding(GO:0043236) |
1.3 | 5.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.3 | 3.8 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
1.3 | 3.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.3 | 3.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 7.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.3 | 11.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.3 | 5.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.3 | 7.6 | GO:0015643 | toxic substance binding(GO:0015643) |
1.3 | 5.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.3 | 5.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.3 | 13.8 | GO:0010181 | FMN binding(GO:0010181) |
1.3 | 30.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.2 | 12.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.2 | 13.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.2 | 3.7 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.2 | 8.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.2 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.2 | 33.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.2 | 1.2 | GO:0043426 | MRF binding(GO:0043426) |
1.2 | 3.7 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
1.2 | 15.9 | GO:0005521 | lamin binding(GO:0005521) |
1.2 | 18.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.2 | 3.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.2 | 7.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.2 | 28.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.2 | 18.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 14.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 4.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.2 | 1.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.2 | 3.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.2 | 2.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.2 | 1.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.2 | 5.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.2 | 7.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.2 | 9.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.2 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.2 | 4.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.2 | 5.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.2 | 4.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.2 | 3.5 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.2 | 1.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.2 | 16.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.2 | 18.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.2 | 2.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.2 | 4.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.2 | 2.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.2 | 3.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 6.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.2 | 5.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.2 | 2.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.1 | 4.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.1 | 3.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.1 | 2.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.1 | 2.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
1.1 | 2.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.1 | 7.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.1 | 1.1 | GO:0070538 | oleic acid binding(GO:0070538) |
1.1 | 5.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.1 | 27.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.1 | 8.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.1 | 18.2 | GO:0045502 | dynein binding(GO:0045502) |
1.1 | 9.6 | GO:0044548 | S100 protein binding(GO:0044548) |
1.1 | 7.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.1 | 2.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.1 | 30.7 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.1 | 3.2 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.1 | 1.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.1 | 9.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.1 | 5.3 | GO:0031491 | nucleosome binding(GO:0031491) |
1.1 | 18.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 2.1 | GO:0035197 | siRNA binding(GO:0035197) |
1.0 | 4.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.0 | 6.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 1.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.0 | 6.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.0 | 13.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.0 | 9.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.0 | 10.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 6.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.0 | 4.1 | GO:0005536 | glucose binding(GO:0005536) |
1.0 | 3.1 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 6.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.0 | 5.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.0 | 7.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
1.0 | 3.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.0 | 5.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.0 | 3.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 3.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.0 | 5.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.0 | 19.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.0 | 1.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.0 | 3.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 4.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.0 | 3.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.0 | 2.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.0 | 16.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.0 | 5.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.0 | 2.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 7.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.0 | 2.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.0 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 1.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 5.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.0 | 154.5 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
1.0 | 2.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.0 | 3.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.0 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 1.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.0 | 14.3 | GO:0008483 | transaminase activity(GO:0008483) |
1.0 | 9.5 | GO:0034781 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.0 | 3.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.9 | 4.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.9 | 2.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.9 | 1.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.9 | 3.8 | GO:0035671 | enone reductase activity(GO:0035671) |
0.9 | 16.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 7.5 | GO:0046977 | TAP binding(GO:0046977) |
0.9 | 5.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.9 | 4.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.9 | 5.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.9 | 2.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 5.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 49.1 | GO:0042393 | histone binding(GO:0042393) |
0.9 | 4.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.9 | 4.6 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.9 | 73.8 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.9 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.9 | 8.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 29.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.9 | 3.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.9 | 2.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.9 | 5.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.9 | 3.6 | GO:0018641 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.9 | 12.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 0.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.9 | 82.5 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.9 | 1.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 6.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.9 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 0.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.9 | 0.9 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.9 | 91.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.9 | 3.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.9 | 3.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.9 | 29.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.9 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.9 | 28.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.9 | 3.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.9 | 5.3 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 1.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.9 | 15.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.9 | 6.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 20.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.9 | 5.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 7.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.9 | 5.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.9 | 5.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.8 | 0.8 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.8 | 3.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.8 | 7.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 8.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 2.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.8 | 1.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.8 | 10.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 2.5 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 10.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.8 | 1.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.8 | 10.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.8 | 1.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.8 | 11.6 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.8 | 8.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 1.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.8 | 1.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.8 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.8 | 7.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 9.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.8 | 13.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.8 | 1.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 28.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.8 | 4.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 0.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.8 | 11.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 5.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.8 | 17.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 2.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.8 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 4.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 15.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.8 | 34.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.8 | 6.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.8 | 10.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.8 | 63.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.8 | 6.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 2.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.8 | 33.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.8 | 10.0 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 3.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 13.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.8 | 3.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 2.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 5.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 20.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.7 | 3.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 3.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.7 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 2.2 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.7 | 8.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.7 | 5.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 20.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.7 | 10.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 5.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 3.6 | GO:0019825 | oxygen binding(GO:0019825) |
0.7 | 16.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.7 | 4.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 1.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.7 | 2.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 1.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.7 | 10.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 9.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 2.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.7 | 1.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.7 | 34.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 1.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 18.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.7 | 0.7 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.7 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 0.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.7 | 3.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 4.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.7 | 2.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.7 | 4.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.7 | 3.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 12.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 4.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 5.3 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.7 | 25.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 11.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 1.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.6 | 27.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 2.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.6 | 3.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 1.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 1.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.6 | 1.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 6.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.6 | 8.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.6 | 8.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 3.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.6 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 30.4 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 2.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 6.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 2.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.6 | 4.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 5.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 3.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 1.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 2.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.6 | 0.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.6 | 1.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.6 | 4.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.6 | 1.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 3.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 4.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.6 | 6.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 4.0 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.6 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 19.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 2.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.5 | 1.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 3.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 13.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 4.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 45.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 1.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.6 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 72.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.5 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 10.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 1.1 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.5 | 1.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 1.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 1.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 3.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 1.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 87.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 14.4 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 3.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 6.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 14.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 2.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 2.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.5 | 13.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 86.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 49.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 1.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.5 | 0.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.5 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 2.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 2.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 7.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.5 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 10.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.5 | 6.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 6.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.5 | 0.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 0.9 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 0.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 2.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 3.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 0.4 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.4 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 8.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 3.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 0.4 | GO:0015927 | trehalase activity(GO:0015927) |
0.4 | 2.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.4 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.4 | 2.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 11.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 2.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 3.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 5.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 6.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 2.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 6.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 17.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.4 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 3.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 1.1 | GO:0018567 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 4.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.4 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 2.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 2.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 1.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 0.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 6.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 3.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 3.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 3.0 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 3.9 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 3.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 2.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 4.1 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.3 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 9.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 21.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 8.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.3 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.3 | 15.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 2.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 8.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 1.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.3 | 4.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.3 | 0.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 3.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 3.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 15.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 5.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 7.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 4.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 2.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 202.0 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 2.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 2.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 1.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 6.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 2.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.2 | 11.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 3.2 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.8 | GO:0016160 | amylase activity(GO:0016160) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 15.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 5.8 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
0.1 | 0.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.5 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.4 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 30.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 5.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 3.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 3.2 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 1.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 0.4 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 1.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 25.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 9.2 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 4.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 1.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 26.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 10.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
5.4 | 5.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
4.2 | 4.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
3.7 | 106.4 | PID IGF1 PATHWAY | IGF1 pathway |
3.5 | 88.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
3.5 | 66.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
3.5 | 31.1 | ST STAT3 PATHWAY | STAT3 Pathway |
3.4 | 44.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
3.4 | 27.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.2 | 31.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.9 | 23.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.9 | 23.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.8 | 14.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.7 | 19.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.6 | 55.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.5 | 38.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.4 | 101.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
2.4 | 40.6 | PID EPO PATHWAY | EPO signaling pathway |
2.3 | 117.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
2.3 | 22.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.3 | 15.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.2 | 31.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.2 | 24.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.2 | 111.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.2 | 4.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
2.2 | 4.4 | PID MYC PATHWAY | C-MYC pathway |
2.1 | 4.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.1 | 16.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.0 | 13.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.9 | 22.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.9 | 22.5 | PID IFNG PATHWAY | IFN-gamma pathway |
1.8 | 76.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.8 | 3.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.8 | 21.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.7 | 55.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.7 | 13.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.7 | 58.0 | PID P53 REGULATION PATHWAY | p53 pathway |
1.7 | 59.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.7 | 33.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.7 | 13.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.6 | 9.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.6 | 17.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.6 | 58.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.6 | 31.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.6 | 34.6 | PID RHOA PATHWAY | RhoA signaling pathway |
1.6 | 70.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.6 | 7.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.5 | 6.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.5 | 37.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.5 | 9.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.5 | 46.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.5 | 23.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.4 | 108.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.4 | 47.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.4 | 12.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.4 | 37.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.4 | 16.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.3 | 9.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.3 | 19.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.3 | 11.5 | ST GAQ PATHWAY | G alpha q Pathway |
1.3 | 3.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.2 | 27.4 | PID ARF6 PATHWAY | Arf6 signaling events |
1.2 | 32.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.2 | 45.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.2 | 7.0 | PID ALK1 PATHWAY | ALK1 signaling events |
1.1 | 3.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 12.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.1 | 18.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.1 | 20.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.1 | 12.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.1 | 21.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.1 | 2.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.0 | 16.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.0 | 16.2 | PID BARD1 PATHWAY | BARD1 signaling events |
1.0 | 29.6 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 10.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.9 | 20.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.9 | 1.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 6.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.8 | 13.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 11.3 | PID ATR PATHWAY | ATR signaling pathway |
0.8 | 3.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 10.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 3.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 16.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 17.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 5.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 20.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 11.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 10.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 8.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.6 | 5.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 4.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 16.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 8.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 11.2 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 4.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 9.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 8.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 5.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 3.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 5.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 42.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 2.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 4.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 5.4 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 1.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 2.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 48.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
4.1 | 4.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
3.7 | 58.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.7 | 7.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
3.5 | 31.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.5 | 3.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.4 | 34.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
3.4 | 51.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
3.4 | 51.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
3.3 | 33.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.3 | 16.4 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
3.3 | 16.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.1 | 6.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
3.1 | 30.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.0 | 8.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
3.0 | 23.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
2.9 | 31.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.9 | 69.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.8 | 65.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.8 | 44.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.7 | 21.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.7 | 43.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.7 | 26.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.7 | 8.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.6 | 15.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.6 | 28.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.6 | 2.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.6 | 2.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.6 | 25.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.6 | 20.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.5 | 30.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.5 | 32.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
2.4 | 19.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 23.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.4 | 26.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.3 | 2.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.3 | 32.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.3 | 32.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.3 | 13.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.3 | 33.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.2 | 22.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.2 | 17.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
2.2 | 19.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.2 | 8.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.1 | 19.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.1 | 98.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.0 | 24.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.0 | 21.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.0 | 45.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.9 | 3.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.9 | 7.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.9 | 28.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.8 | 12.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.8 | 53.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.8 | 136.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.7 | 67.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.7 | 5.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.7 | 45.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.7 | 35.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.7 | 6.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.7 | 16.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.7 | 33.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.6 | 18.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.6 | 14.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.6 | 22.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.6 | 12.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.6 | 17.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.6 | 17.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.6 | 66.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.6 | 22.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.6 | 10.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.6 | 17.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.5 | 12.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.5 | 4.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.5 | 13.8 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.5 | 27.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.5 | 12.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.5 | 7.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.5 | 14.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.5 | 11.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.5 | 16.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.5 | 45.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.4 | 4.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.4 | 28.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.4 | 43.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.4 | 2.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.4 | 13.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.4 | 4.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.4 | 20.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.3 | 26.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.3 | 85.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.3 | 3.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.3 | 28.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.3 | 73.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.3 | 12.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.2 | 13.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.2 | 3.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.2 | 21.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.2 | 19.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.2 | 8.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.1 | 10.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 12.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.1 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.1 | 6.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 7.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.1 | 2.2 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.1 | 31.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.1 | 6.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.0 | 3.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.0 | 90.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.0 | 7.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.0 | 8.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.0 | 21.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 25.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.0 | 9.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.0 | 4.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.0 | 12.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
1.0 | 4.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 18.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.0 | 13.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.0 | 21.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.0 | 42.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 14.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.9 | 3.8 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.9 | 6.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.9 | 7.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.9 | 3.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 4.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.9 | 8.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 66.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.9 | 6.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.8 | 36.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 6.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.8 | 7.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 8.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.8 | 10.6 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.8 | 5.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.8 | 12.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.8 | 9.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 25.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.8 | 12.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 8.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.7 | 1.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.7 | 5.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 1.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 14.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 61.4 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.7 | 30.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 3.9 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.7 | 5.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 11.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 7.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.6 | 14.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 7.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 7.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 17.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 4.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 3.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 18.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 17.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.6 | 10.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 2.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.6 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 10.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 9.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.6 | 2.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 18.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 5.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 6.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 1.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.5 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 0.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 4.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 4.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.5 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.5 | 6.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 6.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.5 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 2.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 9.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 4.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 5.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 4.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 4.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 0.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.4 | 14.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 5.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 10.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 49.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 5.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 5.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.3 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 6.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.3 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 16.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 3.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 3.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 4.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 4.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 2.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 5.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 0.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 5.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 1.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 4.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 5.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 4.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |